No Data
No Data
Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Leaders to Discuss AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024
NEW HOPE, Pa., June 04, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, "Orchestra BioMed" or the "Company"), a biomedical company accelerating high-impact technologies to pa
Orchestra BioMed(OBIO.US) Officer Buys US$28,000 in Common Stock
$Orchestra BioMed(OBIO.US)$ Officer Little William Reed purchased 4,000 shares of common stock on May 30, 2024 at an average price of $7 for a total value of $28,000.Source: Announcement What is state
Does Orchestra BioMed Holdings, Inc. (OBIO) Have the Potential to Rally 135.64% as Wall Street Analysts Expect?
Orchestra BioMed to Participate in Jefferies Global Healthcare Conference
NEW HOPE, Pa., May 22, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO, "Orchestra BioMed" or the "Company")), a biomedical company accelerating high-impact technologies to patients through
(SEC Amendment) Orchestra BioMed(OBIO.US) Officer Buys US$24,950 in Common Stock
$Orchestra BioMed(OBIO.US)$ Officer Hochman David P purchased 5,000 shares of common stock on May 16, 17, 2024 at an average price of $4.99 for a total value of $24,950.Source: Announcement What is st
Express News | Orchestra Biomed Holdings Inc Files for Mixed Shelf of Upto $300 Mln- SEC Filing
No Data